BCL2 overexpression in donor lymphocytes reduces the risk of graft-versus-host disease. [PDF]
Bejarano-García JA +14 more
europepmc +1 more source
Tissue Factor-inhibited Beclin1-autophagy via BCL2 overexpression suppresses the differentiation of human monocytes into mature osteoclasts. [PDF]
Wu L, Gao T, Ke D, Liu G.
europepmc +1 more source
Gene-guided repurposing identifies dihydroergotamine as a candidate inhibitor of the BCL2-SIVA1 axis in advanced gastric cancer in vitro. [PDF]
Huang YL +13 more
europepmc +1 more source
Investigation of potential targets and mechanisms of naringenin in the treatment of spinal cord injury: A network pharmacology, molecular docking, and molecular dynamics simulation study. [PDF]
Li AB, Sheng WB.
europepmc +1 more source
The rearrangement partner and the presence of <i>MYC</i> mutations determine the outcome of patients with <i>MYC</i> and <i>BCL6</i> rearrangements. [PDF]
Stengel A, Lenk M, Kern W, Walter W.
europepmc +1 more source
Correction: <i>In situ</i> formation of transcriptional modulators using non-canonical DNA i-motifs. [PDF]
Saha P +5 more
europepmc +1 more source
Nontranslocation follicular lymphoma mimicking infectious mononucleosis: a diagnostic challenge in a 39-year-old male. [PDF]
Barsh E +5 more
europepmc +1 more source
BCL2-Negative Duodenal-Type Follicular Lymphoma Unmasked After <i>Helicobacter pylori</i> Eradication. [PDF]
Ganju N +4 more
europepmc +1 more source
Effect of Small Nucleolar RNA H/ACA Box 64 (SNORA64) on Apoptosis Regulator Genes in Pancreatic Cancer in Vitro. [PDF]
Alfardan R.
europepmc +1 more source
Venetoclax retreatment in chronic lymphocytic leukemia is biologically rational and clinically effective. [PDF]
Castonguay M +3 more
europepmc +1 more source

